Table 3 Demographic and metabolic characteristics of preeclamptic cases and normotensive controls at 12–24 gestational weeks
Variables | Preeclampsia | Control | p value |
|---|---|---|---|
( N = 24) | ( N = 414) | ||
( Mean ± SEM) | ( Mean ± SEM) | ||
Age (years) | 30.76 ± 3.89 | 31.83 ± 4.19 | 0.35 |
Gravidity | 2.31 ± 1.21 | 2.23 ± 1.01 | 0.90 |
Parity | 0.53 ± 0.21 | 0.54 ± 0.15 | 0.81 |
Prepregnancy BMI (kg/m2) | 8.07 ± 9.71 | 8.49 ± 12.06 | 0.89 |
Systolic Blood Pressure (mmHg) | 112.81 ± 12.24 | 128.12 ± 10.40 | 0.01 |
Diastolic Blood Pressure (mmHg) | 67.27 ± 9.18 | 76.72 ± 7.14 | 0.01 |
HbA1c (%) | 5.06 ± 0.36 | 5.24 ± 0.23 | 0.09 |
FPG (mmol/L) | 5.00 (4.70 ± 5.22) | 4.65 (4.37 ± 4.86) | 0.001 |
1 h PG (mmol/L) | 9.62 (8.34 ± 10.59) | 7.94 (6.73 ± 9.12) | 0.002 |
2 h PG (mmol/L) | 7.06 (6.47 ± 7.95) | 6.91 (6.10 ± 7.81) | 0.51 |
Total Cholesterol (mmol/L) | 5.5 (5.28 ± 6.06) | 5.96 (5.48 ± 6.74) | 0.245 |
HDL-C (mmol/L) | 1.79 (1.41 ± 2.18) | 1.92 (1.66 ± 2.21) | 0.364 |
LDL-C (mmol/L) | 2.42 (1.96 ± 3.24) | 3.13 (2.50 ± 3.57) | 0.044 |
FFA | 0.36 (0.28 ± 0.89) | 0.41 (0.28 ± 0.80) | 0.95 |
sd-LDL | 40.96 (32.80 ± 55.52) | 41.13 (31.71 ± 53.65) | 0.72 |
HOMA-β (%) | 121.34 (104.61 ± 133.48) | 123.06 (92.38 ± 165.20) | 0.606 |
HOMA-IR | 2.25 (1.52 ± 2.86) | 1.34 (1.04 ± 1.83) | 0.004 |
FTG | 2.81 (2.28 ± 3.30) | 2.35 (1.88 ± 3.04) | 0.12 |
4 h TG | 4.20 (3.63 ± 5.12) | 3.38 (2.44 ± 4.33) | 0.037 |
Neonatal weight (g) | 3312.63 ± 405.22 | 2961.66 ± 541.78 | 0.05 |